Targeting potential receptor molecules in non-small cell lung cancer (NSCLC) using in silico approaches

Targeting potential receptor molecules in non-small cell lung cancer (NSCLC) using in silico approaches

Introduction: Non-Small Cell Lung Cancer is the most prevalent type of cancer in lung cancer. Chemotherapy, radiation therapy, and other conventional cancer treatments have a low success rate. Thus, creating new medications is essential to halt the spread of lung cancer.Methods: In this study bioact...

Full description

Bibliographic Details
Main Authors:	C. Kirubhanand, J. Merciline Leonora, S. Anitha, R. Sangeetha, K. T. Nachammai, K. Langeswaran, S. Gowtham Kumar
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Series:	Frontiers in Molecular Biosciences
Subjects:	lochnericine quantum chemical calculations molecular docking molecular dynamics anticancer study non-small lung cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2023.1124563/full

Similar Items

Evodiamine and Rutaecarpine as Potential Anticancer Compounds: A Combined Computational Study
by: Jingli Liu, et al.
Published: (2022-09-01)

Design and Synthesis of New Hydantoin Acetanilide Derivatives as Anti-NSCLC Targeting EGFR<sup>L858R/T790M</sup> Mutations
by: Moamen A. Hassanin, et al.
Published: (2022-07-01)

Molecular docking study of sea urchin (Arbacia lixula) peptides as multi-target inhibitor for non-small cell lung cancer (NSCLC) associated proteins.
by: Muhammad Hermawan Widyananda, et al.
Published: (2021-07-01)

Synthesis, in silico molecular docking analysis, pharmacokinetic properties and evaluation of antibacterial and antioxidant activities of fluoroquinolines
by: Mona Fekadu, et al.
Published: (2022-01-01)

Synthesis, characterization, molecular docking, in silico ADME study, and in vitro cytotoxicity evaluation of new pyridine derivatives of nabumetone.
by: Bushra K. Jameel, et al.
Published: (2023-07-01)

In Silico Screening and Designing Synthesis of Cinchona Alkaloids Derivatives as Potential Anticancer
by: Muhammad Hanafi, et al.
Published: (2017-06-01)

STUDY IN SILICO OF THIOUREA-DERIVED COMPOUNDS AS TYROSINE KINASE RECEPTOR INHIBITORS
by: Budi Mulyati, et al.
Published: (2022-12-01)

In-Silico Assessments of Fruticulin-A and Demethylfruticulin-A Isolated from Salvia Species Against Important Anticancer Targets
by: Hossein Hadavand Mirzaei*, et al.
Published: (2023-07-01)

Synthesis, Anticancer, Antioxidant, Anti-Inflammatory, Antimicrobial Activities, Molecular Docking, and DFT Studies of Sultams Derived from Saccharin
by: Nourah Al-Fayez, et al.
Published: (2022-10-01)

In Vitro and In Silico Evaluation of Antiproliferative Activity of New Isoxazolidine Derivatives Targeting EGFR: Design, Synthesis, Cell Cycle Analysis, and Apoptotic Inducers
by: Fahad Alminderej, et al.
Published: (2023-07-01)

Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes
by: Vineela Parvathaneni, et al.
Published: (2021-04-01)

Identification of Potential Antitubulin Agents with Anticancer Assets from a Series of Imidazo[1,2-<i>a</i>]quinoxaline Derivatives: In Silico and In Vitro Approaches
by: Kapil Kumar Goel, et al.
Published: (2023-01-01)

Anticancer mechanism of Pisangulin angulata through in silico and development as teaching material
by: Agus Muji Santoso, et al.
Published: (2019-04-01)

Phenolic metabolites, biological activities, and isolated compounds of Terminalia muelleri extract
by: Walaa A. El-Kashak, et al.
Published: (2017-01-01)

Conformational analysis, spectroscopic (FTIR, NMR and UV-Vis.), molecular docking and quantum chemical simulation studies of 1-phenylethanone-O-pyropyl oxime ether
by: İlhan KUCUK, et al.
Published: (2018-12-01)

Synthesis, in-silico studies, and biological evaluation of some novel 3-thiazolyl-indoles as CDK2–inhibitors
by: Sobhi M. Gomha, et al.
Published: (2023-12-01)

Thiazolopyrimidine as a Promising Anticancer Pharmacophore: In Silico Drug Design, Molecular Docking and ADMET Prediction Studies
by: Omar A. El-Khouly, et al.
Published: (2022-11-01)

Insights into the structural, electronic, quantum chemical properties and molecular docking studies on novel NAMPT inhibitor molecule
by: K. Deepakvijay, et al.
Published: (2023-12-01)

Molecular docking and dynamic simulations of 2-phenoxyaniline and quantum computational, spectroscopic, DFT/TDDFT investigation of electronic states in various solvents
by: Manoj Kumar, et al.
Published: (2023-12-01)

Napthyridine-derived compounds as promising inhibitors for Staphylococcus aureus CrtM: a primer for the discovery of potential anti-Staphylococcus aureus agents
by: Mohammed Bourhia, et al.
Published: (2023-10-01)

DFT Computations and Molecular Docking Studies of 3-(6-(3-aminophenyl)thiazolo[1,2,4]triazol-2-yl)-2H-chromen-2-one(ATTC) Molecule
by: Ümit Yıldıko, et al.
Published: (2023-03-01)

1,5-Benzothiazepine Derivatives: Green Synthesis, In Silico and In Vitro Evaluation as Anticancer Agents
by: Michelyne Haroun, et al.
Published: (2022-06-01)

Isolation of anticancer bioactive secondary metabolites from the sponge-derived endophytic fungi Penicillium sp. and in-silico computational docking approach
by: Kumaravel Kaliaperumal, et al.
Published: (2023-10-01)

Design, synthesis, anticancer activity and docking studies of novel quinazoline-based thiazole derivatives as EGFR kinase inhibitors
by: M.S. Raghu, et al.
Published: (2023-09-01)

Integrated network pharmacology and in-silico approaches to decipher the pharmacological mechanism of Selaginella tamariscina in the treatment of non-small cell lung cancer
by: Sunil Kumar, et al.
Published: (2023-05-01)

An Efficient Synthesis of 1-(1,3-Dioxoisoindolin-2-yl)-3-aryl Urea Analogs as Anticancer and Antioxidant Agents: An Insight into Experimental and <i>In Silico</i> Studies
by: Obaid Afzal, et al.
Published: (2023-12-01)

Exploring the antibacterial, antidiabetic, and anticancer potential of Mentha arvensis extract through in-silico and in-vitro analysis
by: Shah Faisal, et al.
Published: (2023-07-01)

Development of new bioactive molecules to treat breast and lung cancer with natural myricetin and its derivatives: A computational and SAR approach
by: Shopnil Akash, et al.
Published: (2022-09-01)

Screening and identification of potential inhibitor for visceral leishmaniasis (VL) through computational analysis
by: N. Shaslinah, et al.
Published: (2022-02-01)

Exploring Pyrrolo-Fused Heterocycles as Promising Anticancer Agents: An Integrated Synthetic, Biological, and Computational Approach
by: Roxana-Maria Amărandi, et al.
Published: (2023-06-01)

In-vitro cytotoxicity and in-silico investigation of the anticancer potential of 3-methoxyxanthen-9-one from Garcinia lanceifolia Roxb
by: Md Akbar Hossain, et al.
Published: (2023-01-01)

In silico molecular docking and in vitro analysis of ethanolic extract Ocimum sanctum Linn.: Inhibitory and apoptotic effects against non-small cell lung cancer
by: Ulayatul Kustiati, et al.
Published: (2021-12-01)

Synthesis and in-silico studies of 4-(5-(2-(4-(5-aryl-1,2,4-thiadiazol-3-yl)phenyl)-1H-imidazol-4-yl)-1,3,4-thiadiazol-2-yl)pyridines
by: Shashikala Kethireddy, et al.
Published: (2024-01-01)

Phytochemical, antioxidant, and anticancer assessments of Atriplex halimus extracts: In silico and in vitro studies
by: Mohammed Roubi, et al.
Published: (2023-11-01)

Elucidation of Agonist and Antagonist Dynamic Binding Patterns in ER-α by Integration of Molecular Docking, Molecular Dynamics Simulations and Quantum Mechanical Calculations
by: Sugunadevi Sakkiah, et al.
Published: (2021-08-01)

Multialgorithm-Based Docking Reveals Imidazolidinyl Urea as a Multitargeted Inhibitor for Lung Cancer
by: Shaban Ahmad, et al.
Published: (2023-03-01)

Synthesis, Anticancer Activity, and In Silico Studies of 5-(3-Bromophenyl)-<i>N</i>-aryl-4<i>H</i>-1,2,4-triazol-3-amine Analogs
by: Mohamed Jawed Ahsan, et al.
Published: (2023-10-01)

2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation
by: Mohamed H. Elsherbeny, et al.
Published: (2022-06-01)

Synthesis, Computational, and Anticancer In Vitro Investigations of Aminobenzylnaphthols Derived from 2-Naphtol, Benzaldehydes, and α-Aminoacids via the Betti Reaction
by: Mateusz Kciuk, et al.
Published: (2023-10-01)

Computational Screening for the Anticancer Potential of Seed-Derived Antioxidant Peptides: A Cheminformatic Approach
by: Tsun-Thai Chai, et al.
Published: (2021-12-01)